It will compete directly with Abbott Labs Freestyle Libre non-fingerstick CGM systems
Reiner, J
How Retatrutide Works in Female Bodies Retatrutide operates as a triple agonist medication, simultaneously activating three receptor types that influence metabolism, appetite, and energy expenditure
Cannot redeclare control with same name "grid_3_cta_background_attachment"
Results from the TRIUMPH-1 trial, presented at the American Diabetes Association Scientific Sessions, show potential for retatrutide, an investigational GIP, GLP-1, and glucagon triple hormone receptor agonist, for treating obesity
However, appetite breakthrough often resolves with a dose increase to the next therapeutic level, not a shortened interval